Alt tag

About Us

About Vascular Protection

Vascular disease and its many manifestations, including coronary artery disease (CAD) and peripheral artery disease (PAD), have a major impact on the lives of millions of patients and those around them. Major advances in surgical and medical management strategies have helped healthcare professionals reduce its impact. However, despite these advances, the residual risk of major adverse cardiac events remains high. Research into innovative strategies to address this residual risk is ongoing. Whether it is through the use of different combinations of antithrombotic drugs, reducing lipid levels or other disease mediators, the area of Vascular Protection is exciting and continues to evolve.

 

Meet the Steering Committee

Vascular Adviser is developed in collaboration with a Steering Committee who are experts in the field of Vascular Protection.

The Steering Committee is dedicated to fostering awareness and understanding about new approaches in the prevention, diagnosis, and treatment of vascular diseases.

 

The role of the Steering Committee

  • To provide expert advice on relevant core topics for the Vascular Adviser website
  • To provide insights on website structure and features
  • To provide overall direction and oversight to ensure the independence and clinical relevance of the Vascular Adviser website

 

portrait Professor John Eikelboom

Professor John Eikelboom, MBBS, MSc, FRCPC

  • Associate Professor of Medicine, McMaster University, Ontario, Canada; Senior Investigator, Population Health Research Institute; Haematologist in the Thrombosis Service, Hamilton General Hospital, Ontario, Canada
  • Scientific focus: antithrombotic therapy; mechanisms and genetic determinants of antiplatelet drug resistance; mechanisms and prognosis of bleeding
  • Holds a Heart and Stroke Foundation Career Award, and the Jack Hirsh / Population Health Research Institute Chair in Thrombosis and Atherosclerosis
  • Editorial board member for Thrombosis and Hemostasis
portrait Professor Jeffrey I. Weitz

Professor Jeffrey I. Weitz, MD

  • Professor of Medicine and Biochemistry, McMaster University, Ontario, Canada; Executive Director of the Thrombosis & Atherosclerosis Research Institute, Ontario, Canada
  • Scientific focus: clinical research on prevention, diagnosis and treatment of clotting disorders; basic and translational research on mechanisms of action of anticoagulants and thrombolytic agents
  • Received awards from the Royal College of Physicians, Heart and Stroke Foundation, Canadian Cardiovascular Society, American Heart Association, American College of Physicians, and Atherosclerosis, Thrombosis and Vascular Biology Society as well as the Jack Hirsh and Distinguished Innovator Awards from McMaster University; Fellow of the Royal Society of Canada
  • Member of the American Society for Clinical Investigation, Association of American Physician and the Executive Council of The International Society on Thrombosis and Haemostasis
portrait professor e. sebastian debus

Professor E. Sebastian Debus, MD

  • Professor of Surgery and Chairman, Department of Vascular Medicine, University of Hamburg-Eppendorf, Germany
  • Scientific focus: vascular epidemiology and vascular care; aortic pathologies and peripheral occlusive disease
  • Co-founder of the German Vascular Registry program
  • Secretary General of the European Society for Vascular Surgery; Chair of the North German Society for Vascular Medicine; member of the European Society for Vascular Surgery Guidelines Committee; member of the Board of Directors of the European Journal of Vascular and Endovascular Surgery
portrait professor gilles montalescot

Professor Gilles Montalescot, MD, PhD

  • Professor of Cardiology, University of Paris VI, France; Head of the Cardiology Department and Director of Clinical Research at the Institute of Cardiology, Pitié-Salpêtrière Hospital, Paris, France
  • Scientific focus: interventional cardiology; extensive basic and clinical research on antithrombotic drugs, acute coronary syndrome and stable coronary artery disease
  • Received the J. Valade Prize from the Fondation de France and the J. Escalle Award from the Académie Nationale de Médecine
  • Editorial board member of the European Heart Journal; Chairman of ACTION – an independent academic group for clinical research and education
portrait professor lisa k. jennings

Professor Lisa K. Jennings, PhD

  • Clinical Professor, Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA
  • Scientific focus: platelet and coagulation biology; design and pharmacodynamic evaluations of antiplatelet and antithrombin agents in non-clinical and clinical studies; vascular injury response
  • Awarded research grants by the National Institutes of Health and the American Heart Association
  • Founder, CirQuest Labs; Former Director of the TN-AR-MS (TAM) Clinical Research Consortium and of the Vascular Biology Center of Excellence at the University of Tennessee Health Science Center

The role of the sponsor (Bayer AG)

The sponsor provides financial support for the website, and reviews content to ensure accuracy of information in compliance with established pharmaceutical codes of practice.

Never miss out on the latest news!

Over 4,000 healthcare professionals have already signed up.

The next Bayer sponsored ESC-EHRA Webinar is just ahead of us and will already take place next week. Tuesday May 11, 2021 from 18:00 to 19:00 CEST

Join Prof. Roxana Mehran, Dr. Marcelo Sanmartin Fernandez and Prof. Davide Capodanno in the discussion on the topic “Management of atrial fibrillation patients undergoing PCI: where are we now?”